Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Quoin Pharmaceuticals

Quoin Pharmaceuticals (QNRX) Stock Is Skyrocketing Friday: What's Going On?

Quoin Pharmaceuticals Ltd – ADR (NASDAQ:QNRX) shares are trading higher Friday morning after the company announced a private placement financing of up to $104.5 million. The deal with new and existing institutional investors includes an initial upfront funding of $16.8 million.

12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022

Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Monday's After-Market Session

Gainers Vaxxinity (NASDAQ:VAXX) stock moved upwards by 10.2% to $3.56 during Monday's after-market session. The company's market cap stands at $448.5 million.

inkl

Read news from The Economist, FT, and more,
with one subscription

Why Are Quoin Pharma Shares Trading Higher Today?

Why Are Quoin Pharma Shares Trading Higher Today?

The FDA has accepted Quoin Pharmaceuticals Inc's (NASDAQ:QNRX) Investigational New Drug (IND) application for its licensed formulation, which uses Skinvisible Inc's (OTC:SKVI) Invisicare drug delivery technology. The topical formulation "QRX003" was developed to treat Netherton's Syndrome, a debilitating hereditary disorder that affects the skin, hair, and the immune system. Skinvisible granted Quoin an exclusive, royalty-bearing…

Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022

Upgrades For Coupang Inc (NYSE:CPNG), JP Morgan upgraded the previous rating of Neutral to Overweight. The stock has a 52-week-high of $46.00 and a 52-week-low of $11.91. At the end of the last trading period, Coupang closed at $11.99.

Why Quoin Pharmaceuticals Stock Is Trading Higher

Why Quoin Pharmaceuticals Stock Is Trading Higher

Quoin Pharmaceuticals (NASDAQ: QNRX) shares are trading higher Monday after the company announced it received U.S. Food and Drug Administration clearance to initiate clinical testing for its Investigational New Drug application for QRX003.

12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Intraday Session

1

Organisations

Electronic Arts

Food and Drug Administration

Cantor Fitzgerald

Truist Securities

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

397,435 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play